And epigenetic reprogramming may unlock the repression of Th1-type chemokine secretion, IFN signature genes expression and tumor antigen expression, therefore conditioning tumor from poor T cell infiltration to rich T cell infiltration might ultimately potentiate PD-1 blockade therapy [81,91]. The gene discussed is IFNA1; the disease is neoplasm.